PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-1131

  1. 137 Posts.
    lightbulb Created with Sketch. 50
    And the worry is that the tenuous link may be pushed very hard by those with a vested interest in maintaining their current opioid market….hope the FDA sees beyond that.
    Last edited by the buck: 28/08/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.